pharmacodynamics revised

31
General pharmacology By Mohamad-Hesham Daba,MD,PhD Associate professor of Clinical pharmacology

Upload: mansmanchester

Post on 06-May-2015

6.949 views

Category:

Education


0 download

TRANSCRIPT

Page 1: Pharmacodynamics   revised

General pharmacology

ByMohamad-Hesham Daba,MD,PhD

Associate professor of Clinical pharmacology

Page 2: Pharmacodynamics   revised

Intended learning outcomes• Define pharmacodynamics

• Recognise targets for drug actions

• Classify drug receptors

• Identify agonist, antagonist and partial ag

• Describe graded and quantal dose response curves

• Compare bet. affinity, potency and efficacy

• Define therapeutic index

• Discuss the clinical importance of drug combination

Page 3: Pharmacodynamics   revised

Drug-body interactions

• Pharmacodynamic interactions:

the effects of the drugs on the body

• Pharmacokinetic interactions: the way in which the body handles the

drugs.

Page 4: Pharmacodynamics   revised

PHARMACODYNAMICS

• Mechanisms of drug action:

• Body control systems:

• Receptors

• Ion channels

• Enzymes

• Carrier molecules

Page 5: Pharmacodynamics   revised

Receptors • Definition:

• Receptors are

• protein macromolecules on the surface or within the cell

• that combine chemically with small molecules (ligands)

• and produces physiological regulatory functions.

Page 6: Pharmacodynamics   revised

Membrane receptors

Page 7: Pharmacodynamics   revised
Page 8: Pharmacodynamics   revised

Intracellular receptors

Page 9: Pharmacodynamics   revised

• Ligand: is any molecule that can combine with the receptors. A ligand that activates the receptor is called agonist. A ligand that blocks the receptor is called antagonist.

•  Affinity: it is the empathy of the receptor to the ligand. It determines the ability of the drug to bind to receptors.

• Efficacy: it is the ability of the drug to give certain Emax. It means the ability of the drug to induce effevt

Page 10: Pharmacodynamics   revised

Agonist means a drug that activates the receptors upon binding

Page 11: Pharmacodynamics   revised
Page 12: Pharmacodynamics   revised

Pharmacologic antagonist:

means a drug that binds without activating its receptors and thereby prevents activation by an agonist

Receptor block may be:Reversible antagonism (Competitive antagonism)

the antagonist effect can be overcome by increasing the concentration of agonist

Irreversible antagonism (Non-competitive antagonism)

the antagonist effect cannot be overcome by increasing the concentration of agonist

Page 13: Pharmacodynamics   revised

Partial agonist means a drug that binds to its receptor but produces a smaller effect at full dosage than a full agonist

Page 14: Pharmacodynamics   revised

Dose response relationship curves and their importance

• A. Graded dose-response• Importance: 1 Calculation of the ED50 - Potency

- Equieffective doses

- Relative sensitivity

2 Calculation of the Emax. - Efficacy (intrinsic activity)

Page 15: Pharmacodynamics   revised

• Calculation of the ED50:

• ED50 is the dose that produces 50% of the maximal response in one animal.

• Value of knowing the ED50:

• Comparing the potencies of multiple drugs.

• Comparing the equieffective doses of multiple drugs.

• Calculation of drug efficacy:• Efficacy is the maximal response (Emax) obtained by a drug.

• Value of knowing the Emax:

• Knowing the maximal responding capacity of the organ.

• Differentiation between full agonists and partial agonists.

Page 16: Pharmacodynamics   revised

• Potency versus efficacy: 

• ►Potency: it is the effect of drug in relation to its dose.

• ►Efficacy: it is the ability of the drug to give certain Emax.

 

• Efficacy is more important than potency because it is the major determinant of drug effectiveness while potency has little clinical importance because simply you can increase the dose of a less potent drug to obtain the effect of a more potent one (provided that it is not toxic)

Page 17: Pharmacodynamics   revised

B. Quantal dose-response curve:

• Importance:

Calculation of the ED50

(the dose that gives specific effect in 50% of treated group of animals)

Calculation of the LD50

(the dose that kills 50% of treated animals)

Determination of the therapeutic index

T.I.=LD50/ ED50

(it must be >1)

Page 18: Pharmacodynamics   revised

• The therapeutic index (also known as therapeutic ratio) is a comparison of the amount of a therapeutic agent that causes the therapeutic effect to the amount that causes death (in animal studies) or toxicity (in human studies).

So, in humans

therapeutic index or ratio

=TD50/ ED50

Page 19: Pharmacodynamics   revised

Quick quiz

1.Which branch of pharmacology studies the way drugs work in living organism?

A. Pharmacotherapeutics

B. Pharmacokinitics

C. Pharmacogenitics

D. Pharmacodynamics

E. Pharmacovigilance

Page 20: Pharmacodynamics   revised

Quick quiz

2. A 55-year-old woman with congestive heart failure is to be treated with a diuretic drug. Drugs X and Y have the same mechanism of diuretic action. Drug X in a dose of 5mg produces the same magnitude of diuresis as 500 mg of drug Y. This suggests that:

A. Drug Y is less efficacious than drug X.B. Drug X is about 100 times more potent than drug Y.C. Toxicity of drug X is less than that of drug Y.D. Drug X is a safer drug than drug Y.E. Drug X will have a shorter duration of action than drug Y

because less of drug X is present for a given effect.

Page 21: Pharmacodynamics   revised

Quick quiz

3. In the absence of other drug, pindolol causes an increase in heart rate by activating beta adrenoceptors. In the presence of highly effective beta stimulants, however, pindolol causes a dose-dependent, reversible decrease in heart rate. Therefore pindolol is probably:

A. An irreversible antagonist.B. A physiologic antagonist. C. A chemical antagonist. D. A partial agonist.E. A Spare receptor agonist.

Page 22: Pharmacodynamics   revised

Quick quiz

4. Which of the following provides information about the variation in sensitivity to the drug within the population studied?

A. Maximal efficacy.B. Therapeutic index.C. Drug potency.D. Graded dose-response curve.E. Quantal dose-response curve.

Page 23: Pharmacodynamics   revised

Quick quiz

5. Which of the following provides information about the largest response a drug can produces, regardless of dose?

A. Drug potency.B. Maximal efficacy.C. Mechanism of receptor action.D. Therapeutic index.E. Therapeutic window.

Page 24: Pharmacodynamics   revised

HYPOREACTIVITY TO DRUGS

• Tolerance: decreased response to the same dose of the drug. The same response could be obtained by higher doses. It occurs over a long period

• Tachyphylaxis: it is a type of tolerance, which occurs very rapidly.

Probable mechanisms:1. Change in receptors (desensitization): 2. Loss of receptors (down-regulation): 3. Exhaustion of mediators:4. Increased metabolic degradation:

5. Physiological adaptation:

Page 25: Pharmacodynamics   revised

HYPERREACTIVITY TO DRUGS

overshoot phenomena or hypersusceptibility or intolerance

Up-regulation means increase number of receptors due to prolonged exposure to the antagonist or prolonged deficiency of the natural agonist. When the antagonist is suddenly withdrawn, severe reaction occurs in the form of rebound or withdrawal effects e.g. severe tachycardia & arrhythmia can occur after sudden stoppage of beta-blockers.

Page 26: Pharmacodynamics   revised

DRUG COMBINATION

• Summation and addition: combined effects of two drugs are equal to the sum of their individual effects.

• Synergism or potentiation: combined effects of drugs may be greater than the sum of their individual effects.

• Antagonism: - Chemical antagonism: - Physical antagonism: - Physiological antagonism: - Competitive antagonism: - Non-competitive antagonism

Page 27: Pharmacodynamics   revised

• Which of the following terms best describes the antagonism of leukotriene’s bronchoconstrictor effect (mediated at leukotriene receptors) by terbutaline (acting at adrenoceptors) in a patient with asthma?

1. Pharmacologic antagonist.

2. Partial agonist.

3. Physiologic antagonist.

4. Chemical antagonist.

5. Noncompetitive antagonist.

Page 28: Pharmacodynamics   revised

• Many drugs produce effects by interaction with receptors. Other cellular components with which drugs interact to produce effects include:

1. Nucleic acids.

2. Structural proteins.

3. Enzymes.

4. Proteins involved in transport processes.

5. All of the above.

Page 29: Pharmacodynamics   revised

• Which of the following chemical compounds produce their major effects by binding to intracellular receptors that bind to nuclear DNA?

1. Insulin.

2. Succinylcholine.

3. Catecholamines.

4. Opioid peptides.

5. Steroids.

Page 30: Pharmacodynamics   revised

The term that refers to the rapid diminution of responsiveness following administration of a drug is:

1.hyporeactivity

2.idiosyncratic drug response

3.tolerance

4.drug inactivation

5.tachyphylaxis

Page 31: Pharmacodynamics   revised

MATCH the pharmacologic term in the answers below with the most appropriate definition of the term in the items:

1. Efficacy

2. Potency

3. Tolerance

4. Therapeutic index

5. Intolerance

A) Decreased response to the same dose of the drug.

B) When the antagonist is suddenly withdrawn, severe reaction occurs in the form of rebound or withdrawal effects

C) This is the maximal response obtainable by a drug treatment

D) This is the ratio of the toxic dose to the therapeutic dose

E) This is the amount of drug required to produce a desired effect